Delivery Order SPE2DB22D2211-SPE2DB25FSBSS
- Not listed
- The Defense Logistics Agency awarded a $3,648.80 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price contract, which is part of a larger Indefinite Delivery Contract vehicle, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,545.30 for Trulicity 1.5 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction under AmerisourceBergen's broader federal contract portfolio. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive procurement. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a ceiling value of $2,344.84. This firm fixed-price delivery order, which must be completed by July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award is unclassified as a set-aside contract, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,970.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and carries firm fixed pricing with no set-aside designation. The award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,663.27 for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with performance to be executed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $1,351.35 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed price, competitively awarded contract involves the supply of the diabetes medication from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Trulicity 1.5 mg/0.5 mL pens, with a ceiling value of $1,991.99. The contract is firm fixed price with no set-aside designation and was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $6,462.73 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger federal...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBSSDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,204.98 on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This competitive award employs firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract specifies a performance location in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters. This delivery order represents a routine pharmaceutical supply transaction within DLA's medical supply chain operations, which provision medications and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal medical programs. AmerisourceBergen's comprehensive IDC with DLA enables the company to supply a broad portfolio of pharmaceutical products including specialty medications, generic and brand-name drugs, and medical supplies across multiple therapeutic domains to support global military healthcare requirements. No set-aside designation was applied to this award, indicating it was competitively awarded among qualified vendors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/28/25 |